Related Experiment Videos

In vitro hormonal regulation of astrocyte proliferation

Schweizer Archiv Fur Neurologie Und Psychiatrie (Zurich, Switzerland : 1985)
|January 1, 1989
PubMed

Insights

Dehydroepiandrosterone (DHEA) and its sulfate (DHEA-S) can prevent myelin basic protein (MBP)-induced astrocyte proliferation. These findings suggest DHEA and DHEA-S may modulate astrogliosis during myelin breakdown.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Myelin basic protein (MBP) is known to increase astrocyte proliferation in vitro.
  • This proliferation is hypothesized to contribute to astrogliosis and glial scar formation following in vivo myelin breakdown.
  • Dehydroepiandrosterone (DHEA) and its sulfated derivative (DHEA-S) have been observed to reduce astrocyte proliferation.

Purpose of the Study:

  • To investigate if DHEA and DHEA-S can prevent the mitogenic effect of MBP on astrocytes in vitro.
  • To quantify the effect of DHEA and DHEA-S on MBP-induced astrocyte proliferation.

Main Methods:

  • Combined 3H-Thymidine autoradiography and immunocytochemistry techniques were employed.
  • Primary astrocyte cultures were treated with MBP alone, or in combination with DHEA or DHEA-S.
  • Proliferation was assessed by quantifying silver grains over astrocyte nuclei.

Main Results:

  • MBP treatment alone resulted in a two-fold increase in astrocyte proliferation.
  • Co-treatment with MBP and DHEA reduced the number of silver grains by 2.5-3 fold.
  • Co-treatment with MBP and DHEA-S reduced the number of silver grains by 3-4 fold.

Conclusions:

  • DHEA and DHEA-S significantly inhibit MBP-induced astrocyte proliferation in vitro.
  • These findings suggest a potential role for DHEA and DHEA-S in modulating astrogliosis associated with myelin breakdown.

Related Concept Videos